GREY:MDCGF - Post by User
Comment by
KingKyleon May 30, 2011 2:55pm
245 Views
Post# 18645542
RE: RE: RE: Fpr the very patient
RE: RE: RE: Fpr the very patientIMO, this stock has better/broader technology application vs NVAX yet it trades at 1/4 in market value. Comparing market value alone, MDG should be in the $2.50. So clearly there is room for SP to move up as the FDA hurdles are achieved and production facility becomes operational. Other potential applications does add more value to the technology unlike NVAX cell based VLP.